Caricamento...
Antibody Drug Conjugates: Preclinical Considerations
The development path for antibody drug conjugates (ADCs) is more complex and challenging than for unmodified antibodies. While many of the preclinical considerations for both unmodified and antibody drug conjugates are shared, special considerations must be taken into account when developing an ADC....
Salvato in:
| Pubblicato in: | AAPS J |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer US
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406963/ https://ncbi.nlm.nih.gov/pubmed/25724883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-015-9738-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|